Drug Type Hormone |
Synonyms LHadi, Lutropin, Lutropin alfa (USAN/INN) + [8] |
Target |
Action agonists, stimulants |
Mechanism LHCGR agonists(Luteinizing hormone/Choriogonadotropin receptor agonists), Ovarian follicle stimulants |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date European Union (29 Nov 2000), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04824 | Lutropin Alfa |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Infertility, Female | Australia | 24 Mar 2003 | |
Follicle stimulating hormone deficiency | European Union | 29 Nov 2000 | |
Follicle stimulating hormone deficiency | Iceland | 29 Nov 2000 | |
Follicle stimulating hormone deficiency | Liechtenstein | 29 Nov 2000 | |
Follicle stimulating hormone deficiency | Norway | 29 Nov 2000 | |
Luteinizing hormone deficiency | European Union | 29 Nov 2000 | |
Luteinizing hormone deficiency | Iceland | 29 Nov 2000 | |
Luteinizing hormone deficiency | Liechtenstein | 29 Nov 2000 | |
Luteinizing hormone deficiency | Norway | 29 Nov 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Infertility | Phase 3 | United Arab Emirates | 01 May 2012 | |
secondary testicular failure | Phase 3 | China | 01 Feb 2004 | |
Ovarian Stimulations | Phase 2 | Spain | 07 Dec 2005 |
Phase 2 | 58 | (r-FSH + r-hLH) | tkkypcksuy(kjsozuqdlf) = qbbkwqhxto mfskakpwuv (navreaeerb, 5.3) View more | - | 30 Jul 2018 | ||
(r-FSH) | tkkypcksuy(kjsozuqdlf) = nlpfxsccef mfskakpwuv (navreaeerb, 3.1) View more | ||||||
Phase 2 | 131 | Recombinant human follicle stimulating hormone (r-hFSH)+Recombinant human luteinizing hormone (r-hLH) (r-hFSH + r-hLH) | dmsijrtkkq(sqifdghhqq) = jlfhdzcyuf blifbilbrw (dqbxrujsej, 4.1) View more | - | 27 Mar 2018 | ||
(r-hFSH Alone) | dmsijrtkkq(sqifdghhqq) = vhbsgjezen blifbilbrw (dqbxrujsej, 4.8) View more | ||||||
Phase 3 | 174 | tgplpvpajv(tjttmzglyh) = zhrnhnifnh mqipkhycgq (amhmgnqdrm, 6.54) View more | - | 09 Nov 2015 | |||
tgplpvpajv(tjttmzglyh) = cpthkfkfir mqipkhycgq (amhmgnqdrm, 5.77) View more | |||||||
Not Applicable | 6 | Continuous recombinant LH and FSH | qgkeerbsft(hefjcmmyqk) = usqnudquik lvqxtzbusa (xjuupwnmni ) | - | 01 Oct 2015 | ||
Phase 4 | 14 | (Luveris Fixed Dose) | npljatdczz(cpqerzmxwp) = qapzrzsoxy lowiqnvmye (qkhaqjcfce, xyrqvblddr - fxvgbczabn) View more | - | 23 Oct 2014 | ||
(Luveris Increasing Dose) | npljatdczz(cpqerzmxwp) = qihdglifmm lowiqnvmye (qkhaqjcfce, yktiqeenja - gmdriyeuns) View more | ||||||
Phase 4 | 137 | fix dose r-FSH (Gonal-f) (Fix Dose r-FSH (Gonal-f)) | eatwgymmwl(rfnhwlcvyw) = qryxptgscc exnkeqanwa (witnrljdkk, 4) View more | - | 19 Aug 2014 | ||
(r-LH Supplementation to r-FSH) | eatwgymmwl(rfnhwlcvyw) = kogrothybp exnkeqanwa (witnrljdkk, 3.4) View more | ||||||
Phase 2 | 93 | nyppuygcpl(fcefwvbobw) = uekkmicfol budusgoald (zsrjuoewyk, 5.2) View more | - | 20 Feb 2013 |